The Dopamine Hypothesis: Variations on a Theme

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Psychopharmacology Bulletin

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/978-94-011-6338-5_9
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

  2009cited by this paper
• Social adjustment and cognitive performance of high-risk children.

  1985cited by this paper
• Eye-blinking and cerebral ventricular size in chronic schizophrenic patients.

  1984cited by this paper
• Neuropathological studies of schizophrenia: a selective review.

  1983cited by this paper
• Biological markers in psychiatry and neurology

  1983cited by this paper
• Apomorphine response and subtyping of schizophrenia.

  1983cited by this paper
• Treatment response and ventricular brain enlargement in young schizophrenic patients.

  1983cited by this paper
• Plasma prolactin concentrations and psychopathology in chronic schizophrenia.

  1982cited by this paper
• Increased brain dopamine and dopamine receptors in schizophrenia.

  1982cited by this paper
• MONOAMINE OXIDASE AND SCHIZOPHRENIA

  1982cited by this paper
• Ventricular enlargement in schizophrenia: relationship to positive and negative symptoms.

  1982cited by this paper
• Computed tomography in schizophrenics and normal volunteers. I. Fluid volume.

  1982cited by this paper
• Schizophrenia as a brain disease

  1982cited by this paper
• The dopamine hypothesis: an overview of studies with schizophrenic patients.

  1982cited by this paper
• Normal Ventricles in Young Schizophrenics

  1982cited by this paper
• Neuroleptics and operant behavior: The anhedonia hypothesis

  1982cited by this paper
• Computed tomography of the brain in patients with acute psychosis and in healthy volunteers

  1982cited by this paper
• Computed tomography in schizophreniform disorder and other acute psychiatric disorders.

  1982cited by this paper
• The Evolution of Symptoms in Institutionalized Hebephrenic/Catatonic Schizophrenics

  1982cited by this paper
• Grafts of embryonic substantia nigra reinnervating the ventrolateral striatum ameliorate sensorimotor impairments and akinesia in rats with 6-OHDA lesions of the nigrostriatal pathway.

  1981cited by this paper
• Regional differences in catecholamine formation and metabolism in the rat spinal cord.

  1981cited by this paper
• A probable neuroleptic effect on platelet monoamine oxidase in chronic schizophrenic patients.

  1981cited by this paper
• Positive and Negative Schizophrenia Symptoms and the Role of Dopamine

  1981cited by this paper
• The Schizophrenia Syndrome: Examples of Biological Tools for Subclassification

  1981cited by this paper
• Computerized tomography of the brain in schizophrenic patients

  1981cited by this paper
• Elevation of brain neuroleptic/dopamine receptors in schizophrenia.

  1980cited by this paper
• Perspectives in schizophrenia research

  1980cited by this paper
• Dopamine-beta-hydroxylase and its apparent endogenous inhibitory activity in the plasma of some psychiatric patients.

  1980cited by this paper
• Diagnosis and drug treatment of psychiatric disorders : adults and children

  1980cited by this paper
• Mesolimbicocortical dopamine terminal fields are necessary for normal locomotor and investigatory exploration in rats.

  1980cited by this paper
• Cerebral ventricular enlargement in chronic schizophrenia. An association with poor response to treatment.

  1980cited by this paper
• Is the mesocortical dopaminergic system involved in Parkinson disease?

  1980cited by this paper
• Dopamine-beta-hydroxylase, monoamine oxidase, and schizophrenia.

  1980cited by this paper
• Positive and Negative Schizophrenic Symptoms and the Role of Dopamine

  1980cited by this paper
• Effects of chronic haloperidol on caudate 3H-spiroperidol binding in lesioned rats.

  1979cited by this paper
• Multiple receptors for dopamine

  1979cited by this paper
• Monoamine Mechanisms in Chronic Schizophrenia: Post-Mortem Neurochemical Findings

  1979cited by this paper
• Conditioning compensates the neglect due to unilateral 6-OHDA lesions of substantia nigra in rats.

  1979cited by this paper
• Psychopharmacology : a generation of progress

  1978cited by this paper
• Neuropharmacology and Behavior

  1978cited by this paper
• Schizophrenia in a North Swedish geographical isolate, 1900–1977. Epidemiology, genetics and biochemistry

  1978cited by this paper
• Increased in vivo binding of 3H-pimozide in mouse striatum following repeated administration of haloperidol.

  1978cited by this paper
• Difficulties in comparing catecholamine-related enzymes from the brains of schizophrenics and controls.

  1978cited by this paper
• Burned-out schizophrenia: evidence for age effects on schizophrenic symptomatology.

  1978cited by this paper
• Saccharomyces cerevisiae cell cycle mutant cdc9 is defective in DNA ligase

  1978cited by this paper
• Increased dopamine-receptor sensitivity in schizophrenia.

  1978cited by this paper
• SERUM DOPAMINE‐β‐HYDROXYLASE IN SCHIZOPHRENIC PATIENTS

  1978cited by this paper
• Neuro-regulators and Psychiatric Disorders

  1978cited by this paper
• Binding of 3H-neuroleptics and 3H-apomorphine in schizophrenic brains

  1978cited by this paper
• Amphetamine Psychosis—A Model for Paranoid Schizophrenia?

  1978cited by this paper
• A comparison of equivalent clinical potencies of neuroleptics as used to treat schizophrenia and affective disorders.

  1977cited by this paper
• Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain.

  1977cited by this paper
• Low platelet monoamine oxidase activity and schizophrenia.

  1976cited by this paper
• The Transmethylation Hypothesis: A Quarter of a Century Later

  1976cited by this paper
• Cerebral ventricular size and cognitive impairment in chronic schizophrenia.

  1976cited by this paper
• Biochemistry and schizophrenia (part IV) the neuroleptics--their mechanism of action: a review of the biochemical literature.

  1976cited by this paper
• Dopamine beta-hydroxylase activity in brains of chronic schizophrenic patients.

  1975cited by this paper
• Central dopamine turnover in schizophrenic syndromes.

  1974cited by this paper
• Criteria for subtyping schizophrenia. Clinical differentiation of hebephrenic and paranoid schizophrenia.

  1974cited by this paper
• The diagnosis and understanding of schizophrenia. Part III. Speculations on the processes that underlie schizophrenic symptoms and signs.

  1974cited by this paper
• Post-mortem measurement of enzymes in human brain: evidence of a central noradrenergic deficit in schizophrenia.

  1974cited by this paper
• Platelet monoamine oxidase activity and substrate preferences in schizophrenic patients.

  1974cited by this paper
• Catecholamines in the brain as mediators of amphetamine psychosis.

  1972cited by this paper
• Decarboxylation of Radioactive DOPA by Erythrocytes in Schizophrenia

  1971cited by this paper
• Prospective prediction of hospital stay in schizophrenia.

  1969cited by this paper
• The significance of dopamine-receptor blockade for the mechanism of action of neuroleptic drugs.

  1966cited by this paper
• A quantitative study on the nigro-neostriatal dopamine neuron system in the rat.

  1966cited by this paper
• EVIDENCE FOR THE EXISTENCE OF MONOAMINE-CONTAINING NEURONS IN THE CENTRAL NERVOUS SYSTEM. I. DEMONSTRATION OF MONOAMINES IN THE CELL BODIES OF BRAIN STEM NEURONS.

  1964cited by this paper
• DYNAMIC RESPONSE OF CHEST WALL AND LUNG INJURIES IN RABBITS EXPOSED TO AIR SHOCK WAVES OF SHORT DURATION.

  1964cited by this paper
• Selected Writings of John Hughlings Jackson

  1959cited by this paper
• Paranoid Psychosis in Narcolepsy and the Possible Danger of Benzedrine Treatment

  1938cited by this paper

• Schizophrenia: improving the continuity of care to ensure optimal patient outcomes.

  2012cites this paper
• Effect of donepezil added to atypical antipsychotics on cognition in patients with schizophrenia: An open-label trial

  2009cites this paper
• A Study on the Short Term Outcome in Schizophrenia withReference to Duration of Untreated Psychosis.

  2008cites this paper
• Neuroleptics and the Natural Course of Schizophrenia 325

  2005cites this paper
• Cortical regulation of subcortical dopamine systems and its possible relevance to schizophrenia

  2005cites this paper
• Study of sexuality-related characteristics in young adults with schizophrenia treated with novel neuroleptics and in a comparison group of young adults.

  2003cites this paper
• Neuroleptic withdrawal in treatment-resistant patients with schizophrenia: tardive dyskinesia is not associated with supersensitive psychosis.

  2003cites this paper
• Dopamine in Schizophrenia Dysfunctional Information Processing in Basal Ganglia — Thalamocortical Split Circuits

  2002cites this paper
• Dopamine effect on the mitochondria potential in B lymphocytes of schizophrenic patients and normal controls.

  2002cites this paper
• Untreated initial psychosis: its relation to quality of life and symptom remission in first-episode schizophrenia.

  2000cites this paper
• 6-(18)F-DOPA PET study in patients with schizophrenia. Positron emission tomography.

  2000cites this paper
• The Influence of Schizophrenia and Standard or Atypical Neuroleptics on Sexual and Sociosexual Functioning: A Review

  2000cites this paper
• Effects of antipsychotics, vitamin E, and MK-801 on dopamine dynamics in the rat brain following discontinuation of cocaine.

  1998cites this paper
• BASES BIOLÓGICAS DE LA ESQUIZOFRENIA: ASPECTOS NEUROQUÍMICOS Y NEUROANATÓMICOS

  1998cites this paper
• The effects of early and sustained intervention on the long-term morbidity of schizophrenia.

  1998cites this paper
• Contemporary Approaches to Neuropsychological Assessment

  1997cites this paper
• Psychopathology and Neuropsychological Assessment

  1997cites this paper
• Basic Neurophysiology of Antipsychotic Drug Action

  1996cites this paper
• Exaggerated responsivity of brain dopaminergic system activity in schizophrenia: a preliminary finding of increased variance of plasma homovanillic acid level in a chronic patient.

  1996cites this paper
• The Neurobiology of Schizophrenia

  1996cites this paper
• Schizophrenia and Antipsychotic Somatic Treatment

  1996cites this paper
• Decreased DOPAC in the anterior cingulate cortex of individuals with schizophrenia.

  1995cites this paper
• Visible persistence decay rates for schizophrenics and substance abusers.

  1994cites this paper
• Free radical mechanisms in schizophrenia and tardive dyskinesia.

  1994cites this paper
• Are there neurochemical indicators of risk for schizophrenia?

  1994cites this paper
• A multidimensional approach to analysis of cerebrospinal fluid biogenic amines in schizophrenia: I. Comparisons with healthy control subjects and neuroleptic-treated/unmedicated pairs analyses.

  1994cites this paper
• Noradrenergic and dopaminergic interrelation in schizophrenia.

  1994cites this paper
• Expressive language characteristics of schizophrenic subjects with different medication histories

  1992cites this paper
• Advances in Neuroscience and Schizophrenia

  1992cites this paper
• The catecholaminergic innervation of primate prefrontal cortex.

  1992cites this paper
• Deficits in initial feature registration of schizophrenics and substance abusers.

  1992cites this paper
• Dopamine and norepinephrine activity in schizophrenia. An integrative perspective.

  1991cites this paper
• Effects of acute and chronic clozapine and haloperidol administration on 3-methoxytyramine accumulation in rat prefrontal cortex, nucleus accumbens and striatum.

  1991cites this paper
• Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia.

  1991cites this paper
• Neuroleptics and the natural course of schizophrenia.

  1991cites this paper
• Explorations of Dopamine and Noradrenaline Activity and Negative Symptoms in Schizophrenia: Concepts and Controversies

  1991cites this paper
• Evidence for reduced and dysregulated turnover of dopamine in schizophrenia.

  1990cites this paper
• What Is Left of Attention in Schizophrenia?-Reply

  1990cites this paper
• Cocaine abuse among schizophrenic patients.

  1990cites this paper
• A unifying theory of movement and madness: involvement of free radicals in disorders of the isodendritic core of the brainstem.

  1988cites this paper
• A metaneurobiological synthesis of the schizophrenic syndromes

  1988cites this paper
• Free radical mechanisms in the central nervous system: an overview.

  1988cites this paper
• Plasma amine metabolites before and after withdrawal from neuroleptic treatment in chronic schizophrenic inpatients.

  1988cites this paper
• Brain Emotional Circuits and Psychopathologies

  1988cites this paper
• Startle habituation and sensorimotor gating in schizophrenia and related animal models.

  1987cites this paper
• Molecular Biology and Schizophrenia: Lessons From Huntington's Disease

  1987cites this paper
• Update on Research in Schizophrenia: Report on the Tarrytown Conference, April 13–15, 1986

  1987cites this paper
• The Dopamine Hypothesis of Schizophrenia 20 Years Later

  1987cites this paper
• Preliminary evidence of reduced combined output of dopamine and its metabolites in chronic schizophrenia.

  1987cites this paper
• Psychotherapeutic Drugs and Biogenic Amines

  1984cites this paper